These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2351394)

  • 1. Unusual granular reactivity for carcinoembryonic antigen in malignant mesothelioma.
    Stirling JW; Henderson DW; Spagnolo DV; Whitaker D
    Hum Pathol; 1990 Jun; 21(6):678-9. PubMed ID: 2351394
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoembryonic antigen-like reactivity in malignant mesothelioma. A comparison between different commercially available antibodies.
    Dejmek A; Hjerpe A
    Cancer; 1994 Jan; 73(2):464-9. PubMed ID: 8293414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.
    Zeng L; Fleury-Feith J; Monnet I; Boutin C; Bignon J; Jaurand MC
    Hum Pathol; 1994 Mar; 25(3):227-34. PubMed ID: 7512071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen in tissue diagnosis of malignant mesothelioma.
    Whitaker D; Shilkin KB
    Lancet; 1981 Jun; 1(8234):1369. PubMed ID: 6113338
    [No Abstract]   [Full Text] [Related]  

  • 5. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
    Szpak CA; Johnston WW; Roggli V; Kolbeck J; Lottich SC; Vollmer R; Thor A; Schlom J
    Am J Pathol; 1986 Feb; 122(2):252-60. PubMed ID: 2418688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant peritoneal mesothelioma giving rise to multiple intestinal polyps.
    Mayall FG; Gibbs AR
    Histopathology; 1991 May; 18(5):480-2. PubMed ID: 1885171
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
    Ghosh AK; Butler EB
    J Clin Pathol; 1987 Dec; 40(12):1424-7. PubMed ID: 3323250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
    Mezger J; Lamerz R; Permanetter W
    J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
    Duggan MA; Masters CB; Alexander F
    Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
    Sheibani K; Battifora H; Burke JS
    Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of closed-needle biopsy in the diagnosis of malignant mesothelioma of the pleura.
    Roggli VL
    Chest; 1994 Jan; 105(1):321-2. PubMed ID: 8275772
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.
    Delahaye M; Hoogsteden HC; Van der Kwast TH
    J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoembryonic antigen in pleural effusion. Adenocarcinoma versus mesothelioma].
    Supervía A; Guitart AC; Rubio J; Cornudella R
    Rev Clin Esp; 1992 Feb; 190(2):69-71. PubMed ID: 1561440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations.
    Frisman DM; McCarthy WF; Schleiff P; Buckner SB; Nocito JD; O'Leary TJ
    Mod Pathol; 1993 Mar; 6(2):179-84. PubMed ID: 8483888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell mesothelioma.
    Cook HC
    Histopathology; 1993 Mar; 22(3):294-5. PubMed ID: 8388362
    [No Abstract]   [Full Text] [Related]  

  • 16. [A comparison of the sialyl SSEA-1 antigen and CEA in the histology of malignant mesothelioma, with special reference to adenocarcinoma of the lung].
    Kishimoto T; Okada K; Shimamoto F; Sato T; Ono T
    Gan No Rinsho; 1988 Nov; 34(14):1951-5. PubMed ID: 2462647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies.
    Noguchi M; Nakajima T; Hirohashi S; Akiba T; Shimosato Y
    Hum Pathol; 1989 Jan; 20(1):53-7. PubMed ID: 2912874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma.
    Faravelli B; D'Amore E; Nosenzo M; Betta PG; Donna A
    Cancer; 1984 Mar; 53(5):1194-7. PubMed ID: 6362839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.
    Marshall RJ; Herbert A; Braye SG; Jones DB
    J Clin Pathol; 1984 Nov; 37(11):1215-21. PubMed ID: 6094617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing malignant pleural mesothelioma.
    Martensson G
    Eur Respir J; 1990 Oct; 3(9):985-6. PubMed ID: 2289567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.